Ultradian Diagnostics is a clinical stage medical device company developing a suite of advanced, continuous, wireless biosensor technologies for on-patient monitoring and management of chronic disease. Ultradian's initial focus is the development of a next generation, calibration-free, minimally invasive continuous glucose monitoring (CGM) system, called Biologue, that will fundamentally alter existing paradigms for managing diabetes. The inherent flexibility of Biologue serves as a platform for an expanded menu of minimally invasive and skin-contact diagnostic tests and therapeutic modalities to monitor and manage a variety of chronic disease conditions. Ultradian Diagnostics has entered into a strategic partnership with a lage electronics manufacturer to integrate our Gen 2 CGM electronics into a single chip solutoion. This will simplify our assembly process and eventually lead to a low-cost, totally disposable CGM that can be integrated with an insulin pump to create a closed-loop system. This new technology will also advance the minimally and a non-invasive diagnostic capabilities of the Biologue platform into remote patient monitoring, sports medicine, and military applications.